Non-Invasive Prenatal Test
Non Invasive Prenatal Test Details
Rapid, Accurate, Reliable
CQuentia offers verifi® prenatal tests to safely and non-invasively screen for the most common chromosomal abnormalities as early as 10 weeks gestation using a single maternal blood draw. Genome sequencing is the-most-advanced technique for performing noninvasive prenatal testing with excellent detection rates and a 0.1% false positive rates. Developed by illumina, the verifi® prenatal test uses whole-genome sequencing (WGS), carried out in our CLIA-certified laboratory, to screen for common fetal aneuploidies to provide accurate information for pregnant women regardless of age or risk.
Prenatal Test Options |
|
---|---|
Down Syndrome | Trisomy 21 |
Edwards Syndrome | Trisomy 18 |
Patau Syndrome | Trisomy 13 |
Sex Chrome Aneuploidies |
|
Turner Syndrome | MX |
Triple X | XXX |
Klinefelter Syndrome | XXY |
Jacobs Syndrome | XYY |